Search results for "TotalSeq"

A computer simulation technique known as molecular dynamics will be used to study how G-protein-coupled receptors interact with the intracellular effector inside the cell

EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights

In our SelectScience NGS Forum, genomics leaders discussed the challenges and opportunities driving the next chapter of next-generation sequencing

How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics

This 7th edition eBook provides useful resources, expert insights, and application-based case studies to help simplify your choice when it comes to selecting the best cell counting technology. Learn about key factors and application considerations for your counting needs. Plus, read lab product reviews from your peers to help you buy with confidence.

Experts explore the technologies and innovations transforming organoids into scalable platforms for drug discovery

The new agents are the AI Protocol Conversion agent and the AI Automation agent

New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

As an ambassador for the Women in STEM Network, Dr. Vasiliki E. Kalodimou is mentoring future scientists and redefining what is possible for women

Newly patented MICRO‑TAG platform brings real‑time, in‑cell target engagement to the forefront of drug discovery

New research and clinical evidence are redefining how clinicians detect and manage preeclampsia, with angiogenic biomarker testing offering earlier, clearer insight into maternal risk

Equipping labs with a frictionless R&D environment where execution, analytics, and learning are natively connected

How Emulate's 96-chip AVA™ Emulation System is helping pharmaceutical companies transition to human-relevant testing under new FDA and UK regulatory guidelines

B&R will highlight how these technologies support high throughput, flexibility, and consistent laboratory performance at scale